Since the original description of rheumatoid factor by Waaler' and its documented clinical association with rheumatoid arthritis,2 the detection and quantitation of rheumatoid factor have been hallmarks in the differential diagnosis of autoimmune disease. Its demonstration is a major laboratory contribution to the American Rheumatism Association's diagnostic criteria for rheumatoid arthritis. The rheumatoid factor binding characteristics and linear response range of each method were determined using 11 sera with rheumatoid factor values of <400 IU determined by both methods. The sera were manually diluted using precision pipettes from 1:2 to 1:10 with either Kallestad QM-300 diluent, Beckman buffer, or normal heat-inactivated serum (rheumatoid factor of < 60 IU).
All statistical analyses of results from the two methods including means, standard deviations, Student's t test for matched pairs, and linear regression were performed using the CSS statistical analysis software (Stattsoft Inc, Tulsa, Oklahoma).
Results

PRECISION
The rheumatoid factor values of the six sera examined for within-run precision ranged from 80 IU to 1900 IU. The precision of both methods was high with the coefficient of variation (CV) being less than 500 over the entire range tested (table 1) .
The rheumatoid factor values of the four sera examined for between-run precision ranged from 94 to 1951 IU. The CV for the QM-300 ranged from between 2-5°h and 8&30 (mean = 5.50); the CV for the ICS-II ranged from between 4-10o/ and 1160'o (mean = 8700) ( While the results of the 35 sera, chosen with an initial ICS-II value of > 400 IU, showed good correlation (r = 0 74), significant differences were again recorded, with the QM-300 producing lower values (p = 0 000) (table 3).
DILUTION RECOVERY EXPERIMENT
All 11 sera examined produced similar dilution recovery curves (fig 2) . The curves obtained for sera diluted with Beckman buffer and run on the ICS-II were significantly different from the curves of sera diluted with Kallestad buffer and run on the QM-300 and from the curves of sera diluted with normal human serum and run on both instruments (p = 0-0003 at 1:6 dilution).
Discussion
The results of this study indicate that significantly different rheumatoid factor values can be obtained depending on which nephelometric system is used. There were several important findings.
Firstly, while the rheumatoid factor results for group 1, obtained using the Kallestad QM-300 method, were significantly higher than those obtained using the Beckman ICS-II, the difference was of questionable clinical relevance.
Secondly, and of potential clinical relevance, are the findings associated with group 2 sera and all sera with rheumatoid factor values of >400 IU by both methods. Two apparently conflicting phenomena occurred. Some sera, whose reaction products neared the peak rate of light scatter, had significantly higher values (p = 0 000) determined by the QM-300 compared with the ICS-II system. All sera whose rheumatoid factor values were greater than 400 IU with the Beckman ICS-II system produced significantly lower values (p = 0000) determined by the Kallestad QM-300.
These discrepancies are unlikely to be caused by the instrumentation itself as both instruments' precision and reproducibility are of a high standard. Our results implicate the Beckman buffer as the likely cause. Both in- 
